Tuberculosis Epidemiology and Medical Treatment Efforts in Indonesia in the Year 2020

KnE Life Sciences Pub Date : 2022-09-13 DOI:10.18502/kls.v0i0.11763

Helyani ., Ramadhan Tosepu, Devi Savitri Effendy

引用次数: 0

Abstract

Tuberculosis (TB) is a deadly disease caused by the Mycobacterium tuberculosis bacteria which affects the lungs. Tuberculosis (TB) has become a public health problem in Indonesia and around the world. Tuberculosis prevention is one of the goals of the Sustainable Health Development (SDGs). In the year 2020, 17.3% of TB patients were 45-54 years old, 16.8% were 25-34 years old, and 16.7% were 15-24 years old. The treatment coverage (TC) of Tuberculosis cases in the year 2020 was 41.7%, which was lower than three years ago. Tuberculosis medical treatment needs to be improved since the percentage was (82.7%). Keywords: tuberculosis, mycobacterium, health, lungs

查看原文本刊更多论文

2020年印度尼西亚的结核病流行病学和医疗工作

结核病(TB)是一种由结核分枝杆菌引起的致命疾病，它会影响肺部。结核病(TB)已成为印度尼西亚和世界各地的一个公共卫生问题。预防结核病是可持续卫生发展的目标之一。到2020年，17.3%的结核病患者年龄为45-54岁，16.8%的患者年龄为25-34岁，16.7%的患者年龄为15-24岁。2020年结核病病例治疗覆盖率(TC)为41.7%，低于三年前。结核病的医疗治疗需要改善，因为这一比例为(82.7%)。关键词:肺结核，分枝杆菌，健康，肺

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

KnE Life Sciences

自引率

0.00%

发文量